Piramal to re-enter domestic pharma formulations market, says report
Updated : July 18, 2018 09:14 AM IST
Piramal had exited the domestic formulations market after selling the business to Abbott for $3.7 billion in 2010.
A possible roll-out can be expected in the second half of this fiscal.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more